Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Fitzmaurice

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Forensic Sciences Research|July 16, 2019
Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New ZealandThomas J Sheehan, Hilary J Hamnett, Richard Beasley, et al.
Behavioural Pharmacology|November 3, 2009
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in ratsKatharine A Brennan, Caleb Carati, Rod A Lea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Nigral glutathione deficiency is not specific for idiopathic Parkinson's diseasePaul S Fitzmaurice, Lee Ang, Mark Guttman, et al.
Annals of Neurology|January 6, 2004
Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJunchao Tong, Paul S Fitzmaurice, Lee Cyn Ang, et al.
Brain Research|December 8, 2009
Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the ratKatharine A Brennan, Joyce Colussi-Mas, Caleb Carati, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetaminePaul S Fitzmaurice, Junchao Tong, Mehrdad Yazdanpanah, et al.
Journal of Psychopharmacology (Oxford, England)|July 4, 2007
Benzylpiperazine: a drug of abuse?Alice C Johnstone, Rod A Lea, Katie A Brennan, et al.
Free Radical Biology & Medicine|February 5, 2016
Do glutathione levels decline in aging human brain?Junchao Tong, Paul S Fitzmaurice, Anna Moszczynska, et al.
Behavioural Pharmacology|November 9, 2007
N-benzylpiperazine has characteristics of a drug of abuseKatharine A Brennan, Barbara Lake, Lincoln S Hely, et al.
Psychopharmacology|October 9, 2008
Brain serotonin transporter in human methamphetamine usersStephen J Kish, Paul S Fitzmaurice, Isabelle Boileau, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Forensic Sciences Research|July 16, 2019
Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New ZealandThomas J Sheehan, Hilary J Hamnett, Richard Beasley, et al.
Behavioural Pharmacology|November 3, 2009
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in ratsKatharine A Brennan, Caleb Carati, Rod A Lea, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Nigral glutathione deficiency is not specific for idiopathic Parkinson's diseasePaul S Fitzmaurice, Lee Ang, Mark Guttman, et al.
Annals of Neurology|January 6, 2004
Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyJunchao Tong, Paul S Fitzmaurice, Lee Cyn Ang, et al.
Brain Research|December 8, 2009
Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the ratKatharine A Brennan, Joyce Colussi-Mas, Caleb Carati, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetaminePaul S Fitzmaurice, Junchao Tong, Mehrdad Yazdanpanah, et al.
Journal of Psychopharmacology (Oxford, England)|July 4, 2007
Benzylpiperazine: a drug of abuse?Alice C Johnstone, Rod A Lea, Katie A Brennan, et al.
Free Radical Biology & Medicine|February 5, 2016
Do glutathione levels decline in aging human brain?Junchao Tong, Paul S Fitzmaurice, Anna Moszczynska, et al.
Behavioural Pharmacology|November 9, 2007
N-benzylpiperazine has characteristics of a drug of abuseKatharine A Brennan, Barbara Lake, Lincoln S Hely, et al.
Psychopharmacology|October 9, 2008
Brain serotonin transporter in human methamphetamine usersStephen J Kish, Paul S Fitzmaurice, Isabelle Boileau, et al.
Pageof 2